This panel is ideal for individuals with a personal or family history of breast and/or ovarian cancer. It examines 50 genes linked to hereditary cancer syndromes, including BRCA1 and BRCA2, and offers comprehensive insight into inherited risks. A simple blood draw unlocks a deeper understanding of genetic predisposition, allowing at-risk individuals and their families to make proactive health decisions. The results can influence screening schedules, surgical prevention strategies, and family counseling. It’s a powerful tool for both prevention and early detection, providing actionable information that could save lives.